Approving a makeup sample is not the same as saying, “This looks good.” A useful approval tells the manufacturer exactly which formula, shade, finish, component, artwork version, and reference the brand has accepted—and which conditions still need to be resolved before bulk production.
This checklist is designed for beauty-brand product, sourcing, and quality teams reviewing a pre-production color-cosmetics sample. It does not replace product-specific technical, safety, stability, compatibility, or regulatory review. Its purpose is to create a clear handoff between sample development and the next production decision.
First, identify what you are approving
Before reviewing appearance or performance, confirm the identity of the sample. The approval record should point to one controlled version rather than an email thread containing several similar prototypes.
- project and product name;
- sample or formula version;
- shade name, code, or reference;
- product format and finish;
- date received and review date;
- package, pan, applicator, or component version;
- artwork or decoration version, if included;
- reviewers and final decision owner.
If the formula and packaging arrived separately, say so. A formula approved in a laboratory container is not automatically an approval of the final filled package.
Review the sample against the brief—not memory
A reference product, mood board, or earlier sample can help communicate direction, but the approval should be tied to the brand’s written requirements. Review the product against the intended format, shade, finish, application method, package, market, and user experience.
| Review area | Questions for the approval team |
|---|---|
| Identity | Is this the correct version, shade, formula route, and component set? |
| Appearance | Does the shade, surface, finish, fill level, and presentation match the approved direction? |
| Application | Does pickup, glide, spread, payoff, coverage, or blending align with the documented product concept? |
| Package function | Does the component open, close, dispense, protect, and present the product as intended? |
| Commercial handoff | Are quantity, component, artwork, market, and open decisions sufficiently clear for the next quotation or production step? |
Evaluate color under controlled conditions
Color judgments can change with lighting, background, application thickness, substrate, camera settings, and the observer. For color cosmetics, document how the shade was reviewed. Use the same agreed viewing conditions and comparison method whenever practical.
Record whether the team reviewed the product in the pan or package, as an application or drawdown, and against which approved reference. Do not rely only on a phone photograph. Images are useful communication tools, but they may not reproduce color consistently across devices.
Approval of aesthetic shade direction is also separate from regulatory suitability. For products intended for the United States, the FDA states that color additives must be permitted for their intended use, and some are subject to batch certification. Market-specific review belongs with qualified regulatory and technical parties.
Separate formula approval from packaging approval
A pre-production sample may combine several decisions:
- the bulk formula;
- the shade and finish;
- the primary package and applicator;
- the filling presentation;
- decoration, label, and artwork;
- secondary packaging.
Approve each layer explicitly. If a stock compact is accepted but the final decoration sample is pending, the record should say “component approved; decoration pending” rather than “packaging approved.” If the filled sample has not completed the project’s required compatibility or stability work, do not let a visual approval imply that those checks are complete.
Use actionable feedback when a revision is needed
Feedback such as “not premium enough” or “make it stronger” is difficult to reproduce. A better revision request identifies what was observed, how it differs from the target, and which direction should change.
For example:
- “The finish appears more reflective than Reference B under the agreed viewing light; move toward the softer-sheen direction shown in Sample 2.”
- “Pickup is acceptable, but the application shows more loose fallout than the approved benchmark using the agreed brush method.”
- “The cap and base are approved; logo placement should move according to the attached marked artwork.”
Consolidate comments before sending them. Conflicting instructions from marketing, product, sourcing, and management can create unnecessary sample rounds.
Record one of four decisions
- Approved. The identified version is accepted for the stated next step.
- Approved with open items. The approved elements and unresolved elements are listed separately.
- Revision requested. The required change and comparison reference are documented.
- Not approved. The version is closed and should not be used as the production reference.
Avoid conditional language that can be interpreted differently by different teams. If approval depends on a later test, packaging sample, artwork proof, or commercial confirmation, name that dependency.
Minimum approval record
A concise record can include:
- project, SKU, sample, formula, shade, and component identifiers;
- approved attributes and references;
- open items and responsible owner;
- review method and relevant conditions;
- decision, date, and approver;
- files attached, including marked artwork or comparison images;
- next authorized step.
The FDA’s cosmetics GMP guidance highlights written manufacturing instructions, acceptance specifications, batch identification, sampling, testing, and production records. Although a brand’s sample-approval form is not the manufacturer’s complete batch record, the same discipline—clear identity, criteria, decision, and traceability—makes the handoff more reliable.
Before you authorize bulk production
Confirm that the approval covers the correct formula and component combination, the remaining technical and regulatory responsibilities are understood, commercial terms are separately confirmed, and the manufacturer has acknowledged the version to be used. Keep a retained reference where appropriate and agree how later batches will be compared.
If your team is still developing prototypes, start with the guide to how cosmetic sampling works. For the wider project sequence, review the private-label business process.
When you are ready to discuss a color-cosmetics project, contact AKIACO with the product format, current sample version, shade and finish direction, packaging status, target market, expected order scope, and the decisions that remain open.
